The One and Only
Preventative Cancer Supportive Care Shield

Discover Tarian Gel

An Innovative Approach to Manage Skin Toxicities

Tarian Gel A New Standard in Skin Protection
What It Is

Tarian Gel: A New Standard in Skin Protection

At Tarian Pharma, we believe that supportive care deserves the same attention as primary cancer treatment. For too long, skin side effects have been accepted as collateral damage — discomfort patients must endure in silence. We see things differently.
Our ambition is clear: to transform the way dermatological toxicities are managed in oncology. We believe that skin toxicities should not inhibit a life-saving protocol. We aim for a future where every cancer treatment journey is supported from the surface to the core where healing doesn’t come at the cost of dignity, pain, or isolation.
Our ambition is for cancer care to embrace holistic patient treatment, not just the cancer itself. 
How It Works

Developed with oncologists and designed for patients

Cancer diagnosis and cancer treatment are traumatizing. We believe supportive care should support maximized cancer treatment protocols and should be easily integrated into protocols and daily life to limit patient distress. That’s why these aspects were included in the design of Tar-0520 / Tarian Gel.
Picto Tarian Pharma
Maximize cancer
treatment outcome
Picto Tarian Pharma
Insignificant systemic exposure
Picto Tarian Pharma
Easily included
into cancer therapy
Picto Tarian Pharma
Excellent local tolerance
Picto Tarian Pharma
Comfortable home use
Picto Tarian Pharma
Eases patient journey
Tarian Gel Designed Around the Patient
Tarian Gel Protection Is Power
Why It Matters

Protection Is Power

Dermatological side effects are among the most frequent and disruptive complications of cancer treatment. Rashes, burns, folliculitis, hairloss and painful skin reactions can lead to emotional distress, social withdrawal, and, in too many cases, treatment interruption.
We believe that skin protection should be proactive, not reactive.
That’s why our formula is the result of over 200 formulation prototypes, developed and refined over two years by experts in dermatology and pharmaceutical science.

Our shield is:

  • Scientifically validated for safety and tolerability
  • Built to empower both patients and physicians
  • A real answer to a clinical need — not a cosmetic workaround
It protects treatment outcomes, supports emotional resilience, and preserves the dignity of care.
Action

Mechanism of action

Tarian Gel mimics the effects of cooling devices by inducing a transient yet effective vasoconstriction of superficial cutaneous blood vessels. Instead of relying on physical cooling, it achieves controlled pharmacological vasoconstriction—offering the key advantage of being painless while allowing for precise alignment with the pharmacokinetics of each chemotherapeutic.
By modulating cutaneous microcirculation, Tarian Gel reduces local bioavailability of chemotherapeutic agents, aiding in the prevention of dermatologic adverse events.
The active ingredient, brimonidine tartrate, is a selective alpha-2 adrenergic receptor agonist responsible for this vasoconstrictive effect.